Cargando…

Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients

The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Haciislamoglu, Emel, Canyilmaz, Emine, Gedik, Sonay, Aynaci, Ozlem, Serdar, Lasif, Yoney, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612689/
https://www.ncbi.nlm.nih.gov/pubmed/31231982
http://dx.doi.org/10.1002/acm2.12668
_version_ 1783432916711243776
author Haciislamoglu, Emel
Canyilmaz, Emine
Gedik, Sonay
Aynaci, Ozlem
Serdar, Lasif
Yoney, Adnan
author_facet Haciislamoglu, Emel
Canyilmaz, Emine
Gedik, Sonay
Aynaci, Ozlem
Serdar, Lasif
Yoney, Adnan
author_sort Haciislamoglu, Emel
collection PubMed
description The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT(DC(−)), IMRT(DC(+)), HT(DC(−)), and HT(DC(+)), respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (V (30) < 50%) and mean dose of thyroid (TD(mean)) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD(mean) and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (V (10), V (20), V (30), V (40), and V (50), respectively) were also analyzed. The D(mean) of the FinF, IMRT(DC(−)), HT(DC(−)), IMRT(DC(+)) and HT(DC(+)) plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V(30) values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT(DC(−)), HT(DC(−)), IMRT(DC(+)), and HT(DC(+)), respectively. Differences between treatment plans with or without DC with respect to D (mean) and V (30) values were statistically significant (P < 0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD(mean) and V (30) values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.
format Online
Article
Text
id pubmed-6612689
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66126892019-07-16 Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan J Appl Clin Med Phys Radiation Oncology Physics The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT(DC(−)), IMRT(DC(+)), HT(DC(−)), and HT(DC(+)), respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (V (30) < 50%) and mean dose of thyroid (TD(mean)) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD(mean) and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (V (10), V (20), V (30), V (40), and V (50), respectively) were also analyzed. The D(mean) of the FinF, IMRT(DC(−)), HT(DC(−)), IMRT(DC(+)) and HT(DC(+)) plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V(30) values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT(DC(−)), HT(DC(−)), IMRT(DC(+)), and HT(DC(+)), respectively. Differences between treatment plans with or without DC with respect to D (mean) and V (30) values were statistically significant (P < 0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD(mean) and V (30) values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended. John Wiley and Sons Inc. 2019-06-24 /pmc/articles/PMC6612689/ /pubmed/31231982 http://dx.doi.org/10.1002/acm2.12668 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Haciislamoglu, Emel
Canyilmaz, Emine
Gedik, Sonay
Aynaci, Ozlem
Serdar, Lasif
Yoney, Adnan
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title_full Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title_fullStr Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title_full_unstemmed Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title_short Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
title_sort effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612689/
https://www.ncbi.nlm.nih.gov/pubmed/31231982
http://dx.doi.org/10.1002/acm2.12668
work_keys_str_mv AT haciislamogluemel effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients
AT canyilmazemine effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients
AT gediksonay effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients
AT aynaciozlem effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients
AT serdarlasif effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients
AT yoneyadnan effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients